Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent HPV vaccination after treatment of high-grade anal intraepithelial neoplasia in HIV-positive men
2013-002009-70Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of qHPV vaccine in anal intraepithelial neoplasia (AIN), human papillomavirus infection and human immunodeficiency virus infection (HIV), sponsored by Academic Medical Center. Primary endpoint: Cumulative recurrence of intra-anal or peri-anal high-grade AIN at 12 months. Started Sep 2013; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
anal intraepithelial neoplasia (AIN)human papillomavirus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2013-002009-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002009-70.